Authors/Disclosures
|
Edward Y. Zamrini, MD
(Irvine Clinical Research)
|
Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
David H. Margolin, MD, PhD
(Genzyme Corporation)
|
Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Richard D. King, MD, PhD, FAAN
(University of Kentucky Neurology Dept)
|
Dr. King has nothing to disclose. |
|
Norman L. Foster, MD, FAAN
(ProActive Memory Services)
|
No disclosure on file |